|
Market Cap | 45.43M | EPS (ttm) | -0.49 |
P/E | - | EPS this Y | 37.78% |
Forward P/E | - | EPS next Y | 92.86% |
PEG | - | EPS past 5Y | 30.03% |
P/S | 1.32 | EPS next 5Y | 10.00% |
P/B | 0.73 | EPS Q/Q | -11.23% |
Dividend | - | Sales Q/Q | -20.43% |
Insider Own | 17.16% | Inst Own | 15.83% |
Insider Trans | 84.09% | Inst Trans | -15.88% |
Short Float | 0.88% | Earnings | May 15/a |
Analyst Recom | 1.00 | Target Price | 8.75 |
Avg Volume | 87.65K | 52W Range | 1.83 - 3.60 |
|
|
|
IZEA Worldwide, Inc. engages in the creation and operation of online marketplaces that connect marketers with content creators under IZEAx platform. It automates influencer marketing and custom content development, which allows brands and agencies to scale their marketing programs. The company was founded by Edward Hans Murphy in February 2006 and is headquartered in Orlando, FL. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
GP Investments, Ltd. | 10% Owner | May 16 '24 | Buy | 2.77 | 178,330 | 493,974 | 3,002,036 | May 16 08:45 PM | GP Investments, Ltd. | 10% Owner | May 14 '24 | Buy | 3.20 | 928,114 | 2,969,965 | 2,823,706 | May 16 08:45 PM | GP Investments, Ltd. | 10% Owner | May 10 '24 | Buy | 3.14 | 102 | 320 | 1,895,592 | May 13 06:33 PM | GP Investments, Ltd. | 10% Owner | May 09 '24 | Buy | 3.06 | 38,021 | 116,344 | 1,895,490 | May 13 06:33 PM | GP Investments, Ltd. | 10% Owner | May 03 '24 | Buy | 3.00 | 1,427 | 4,281 | 1,857,469 | May 03 06:21 PM |
|
|
|
|
Market Cap | 259.20M | EPS (ttm) | -0.57 |
P/E | - | EPS this Y | -68.86% |
Forward P/E | - | EPS next Y | 33.80% |
PEG | - | EPS past 5Y | - |
P/S | - | EPS next 5Y | - |
P/B | - | EPS Q/Q | 0.83% |
Dividend | - | Sales Q/Q | - |
Insider Own | 29.67% | Inst Own | 51.33% |
Insider Trans | -27.51% | Inst Trans | 2.15% |
Short Float | 22.90% | Earnings | May 10/b |
Analyst Recom | 1.80 | Target Price | 4.40 |
Avg Volume | 778.31K | 52W Range | 1.12 - 13.51 |
|
|
|
ProKidney Corp. is a clinical-stage biotechnology company, which engages in the development of a proprietary cell therapy platform. The firm focuses on the treatment of chronic kidney disease, shifting the emphasis away from management of kidney failure to the restoration of kidney function to stop or delay progression of CKD. It offers REACT, a product candidate that includes selected renal cells prepared from a patient's own, autologous, and renal cells. The company was founded on December 21, 2015 and is headquartered in Winston-Salem, NC. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Weber Darin J. | SVP of Regulatory Development | Apr 22 '24 | Sale | 2.51 | 16,438 | 41,315 | 155,194 | Apr 23 04:05 PM | Weber Darin J. | SVP of Regulatory Development | Apr 18 '24 | Sale | 2.54 | 800 | 2,028 | 171,632 | Apr 23 04:05 PM | Weber Darin J. | SVP of Regulatory Development | Apr 16 '24 | Sale | 2.50 | 17,238 | 43,095 | 172,432 | Apr 17 06:57 PM | Weber Darin J. | SVP of Regulatory Development | Apr 12 '24 | Sale | 1.73 | 84,103 | 145,498 | 189,670 | Apr 16 04:54 PM | Weber Darin J. | SVP of Regulatory Development | Apr 01 '24 | Sale | 1.69 | 300 | 507 | 273,773 | Apr 16 04:54 PM |
|
|
|
|
Market Cap | 49.24M | EPS (ttm) | -0.09 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | -55.14% |
P/S | 0.67 | EPS next 5Y | 22.50% |
P/B | 2.29 | EPS Q/Q | 151.26% |
Dividend | - | Sales Q/Q | -2.62% |
Insider Own | 18.40% | Inst Own | 40.89% |
Insider Trans | -0.88% | Inst Trans | -8.38% |
Short Float | 0.06% | Earnings | May 09/b |
Analyst Recom | 1.00 | Target Price | 20.00 |
Avg Volume | 26.58K | 52W Range | 8.79 - 16.85 |
|
|
|
BK Technologies Corp. is a holding company, which engages in the provision of two-way radio communications equipment. It offers product to the fire, EMS, police, federal, and municipalities agencies. The company was founded on October 24, 1997 and is headquartered in West Melbourne, FL. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Horowitz Joshua | Director | May 16 '24 | Buy | 13.77 | 8,169 | 112,462 | 80,809 | May 16 08:07 PM | Horowitz Joshua | Director | May 15 '24 | Buy | 13.45 | 5,572 | 74,953 | 72,640 | May 16 08:07 PM | Horowitz Joshua | Director | May 14 '24 | Buy | 13.23 | 2,893 | 38,280 | 67,068 | May 16 08:07 PM | Fundamental Global GP, LLC | 10% Owner | Jan 30 '24 | Sale | 12.29 | 7,053 | 86,681 | 248,975 | Jan 31 07:22 PM | Fundamental Global GP, LLC | 10% Owner | Jan 29 '24 | Sale | 12.49 | 13,906 | 173,686 | 256,028 | Jan 31 07:22 PM |
|
|
| |
|
Market Cap | 32.66M | EPS (ttm) | -1.09 |
P/E | - | EPS this Y | 10.61% |
Forward P/E | - | EPS next Y | 23.55% |
PEG | - | EPS past 5Y | 2.69% |
P/S | 0.59 | EPS next 5Y | - |
P/B | 1.63 | EPS Q/Q | 57.32% |
Dividend | - | Sales Q/Q | 28.36% |
Insider Own | 25.01% | Inst Own | 35.78% |
Insider Trans | 0.48% | Inst Trans | -0.85% |
Short Float | 0.03% | Earnings | May 13/b |
Analyst Recom | 1.33 | Target Price | 6.00 |
Avg Volume | 45.33K | 52W Range | 1.30 - 3.79 |
|
|
|
Exagen, Inc. is a commercial-stage diagnostics company, which engages in transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic intervention. It operates under the Avise brand. The company was founded by Waneta C. Tuttle and Cole Harris in 2002 and is headquartered in Vista, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
ABALLI JOHN | President and CEO | May 16 '24 | Buy | 1.92 | 40,401 | 77,570 | 40,401 | May 16 08:02 PM | Adawi Kamal | CFO and Corporate Secretary | Mar 04 '24 | Sale | 1.91 | 12,784 | 24,407 | 243,749 | Mar 06 04:05 PM | Adawi Kamal | CFO and Corporate Secretary | Feb 06 '24 | Sale | 1.95 | 6,738 | 13,133 | 181,533 | Feb 08 04:05 PM | ABALLI JOHN | President and CEO | Oct 17 '23 | Sale | 1.75 | 33,819 | 59,018 | 415,984 | Oct 18 04:05 PM | TULLIS JAMES L L | 10% Owner | Jun 15 '23 | Buy | 3.11 | 167 | 519 | 1,515,839 | Jun 20 05:04 PM |
|
|
|
|
Market Cap | 124.46M | EPS (ttm) | -1.07 |
P/E | - | EPS this Y | -508.33% |
Forward P/E | - | EPS next Y | 49.68% |
PEG | - | EPS past 5Y | - |
P/S | 0.31 | EPS next 5Y | - |
P/B | 0.38 | EPS Q/Q | -7986.04% |
Dividend | - | Sales Q/Q | 24.10% |
Insider Own | 30.26% | Inst Own | 71.26% |
Insider Trans | -0.16% | Inst Trans | 32.39% |
Short Float | 17.96% | Earnings | May 09/b |
Analyst Recom | 2.71 | Target Price | 4.08 |
Avg Volume | 3.54M | 52W Range | 1.70 - 28.13 |
|
|
|
Amylyx Pharmaceuticals, Inc. is a commercial-stage biotechnology company, which engages in the provision of therapies for neurodegenerative diseases and amyotrophic lateral sclerosis (ALS). Its commercial product is Relyvrio, also known as Albrioza in Canada. The company was founded by Joshua Cohen and Justin Klee in 2013 and is headquartered in Cambridge, MA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Quimi Daphne | Director | May 15 '24 | Buy | 1.89 | 2,250 | 4,252 | 5,000 | May 16 07:37 PM | Mazzariello Gina | Chief Legal Officer | May 15 '24 | Sale | 1.88 | 10,455 | 19,654 | 151,477 | May 16 07:36 PM | Quimi Daphne | Director | May 14 '24 | Buy | 1.89 | 2,750 | 5,184 | 2,750 | May 16 07:37 PM | Klee Justin B. | Co-Chief Executive Officer | Mar 05 '24 | Sale | 18.73 | 4,135 | 77,440 | 2,959,308 | Mar 07 04:05 PM | Cohen Joshua B | Co-Chief Executive Officer | Mar 05 '24 | Sale | 18.73 | 4,135 | 77,440 | 3,023,002 | Mar 07 04:05 PM |
|
|
| |
|
Market Cap | 337.65M | EPS (ttm) | -0.66 |
P/E | - | EPS this Y | 259.20% |
Forward P/E | 10.96 | EPS next Y | 38.33% |
PEG | - | EPS past 5Y | - |
P/S | 1.29 | EPS next 5Y | 16.00% |
P/B | 2.65 | EPS Q/Q | 101.98% |
Dividend | - | Sales Q/Q | 8.56% |
Insider Own | 32.61% | Inst Own | 62.63% |
Insider Trans | 0.24% | Inst Trans | -9.68% |
Short Float | 3.21% | Earnings | May 07/a |
Analyst Recom | 1.33 | Target Price | 22.20 |
Avg Volume | 402.81K | 52W Range | 7.97 - 18.45 |
|
|
|
Turtle Beach Corp. engages in the development, commercialization, and marketing of audio peripherals. The firm provides gaming accessory. The company was founded by Elwood G. Norris and James A. Barnes in 1975 and is headquartered in White Plains, NY. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Jimenez Terry | Director | May 14 '24 | Buy | 16.37 | 2,025 | 33,149 | 40,909 | May 16 07:23 PM | Jimenez Terry | Director | May 09 '24 | Buy | 16.25 | 2,025 | 32,906 | 38,884 | May 13 05:27 PM | Scherping Katherine Lee | Director | Jun 05 '23 | Buy | 10.75 | 500 | 5,375 | 15,857 | Jun 06 04:05 PM | Scherping Katherine Lee | Director | Jun 02 '23 | Buy | 11.00 | 500 | 5,500 | 15,357 | Jun 06 04:05 PM | Jimenez Terry | Director | May 19 '23 | Buy | 11.59 | 2,500 | 28,975 | 26,551 | May 22 06:11 PM |
|
|
|
|
Market Cap | 19.78M | EPS (ttm) | -0.71 |
P/E | - | EPS this Y | 28.57% |
Forward P/E | - | EPS next Y | 60.00% |
PEG | - | EPS past 5Y | -34.55% |
P/S | 0.24 | EPS next 5Y | - |
P/B | - | EPS Q/Q | -210.37% |
Dividend | - | Sales Q/Q | -22.26% |
Insider Own | 63.27% | Inst Own | 2.90% |
Insider Trans | 0.21% | Inst Trans | - |
Short Float | 0.22% | Earnings | May 09/a |
Analyst Recom | - | Target Price | - |
Avg Volume | 25.37K | 52W Range | 0.76 - 13.00 |
|
|
|
CaliberCos, Inc. is an asset management firm, which creates, manages, and services proprietary products including middlemarket investment funds, private syndications, and direct investments. It operates through the following segments: Fund Management, Development, and Brokerage. The Fund Management segment refers to the fund management activities along with back office and corporate support functions including accounting and human resources. The Development segment focuses on the activities associated with providing real estate development services as their principal developer. The Brokerage segment is involved in the buying, selling, and leasing of all funds assets. The company was founded by John Christopher Loeffler II and Jennifer Schrader in January 2009 and is headquartered in Scottsdale, AZ. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
LEUNG JADE | CFO | May 15 '24 | Buy | 0.87 | 28,500 | 24,704 | 672,052 | May 16 06:30 PM | LOEFFLER JOHN C II | CEO | Nov 13 '23 | Buy | 1.42 | 6,000 | 8,520 | 317,131 | Nov 14 08:06 PM | LOEFFLER JOHN C II | CEO | Sep 05 '23 | Buy | 1.58 | 10,000 | 15,830 | 10,000 | Sep 06 09:25 PM | HANSEN DANIEL PAUL | Director | Aug 31 '23 | Buy | 1.50 | 25,000 | 37,490 | 59,012 | Sep 05 07:04 PM | HANSEN DANIEL PAUL | Director | Aug 29 '23 | Buy | 1.50 | 5,436 | 8,154 | 34,012 | Aug 30 07:59 PM |
|
|
| |
|
Market Cap | 2.99B | EPS (ttm) | 0.64 |
P/E | 30.03 | EPS this Y | 30.42% |
Forward P/E | 20.72 | EPS next Y | 12.78% |
PEG | 3.00 | EPS past 5Y | -3.78% |
P/S | 2.42 | EPS next 5Y | 10.00% |
P/B | 3.96 | EPS Q/Q | 108.17% |
Dividend | 1.35% | Sales Q/Q | 6.16% |
Insider Own | 1.93% | Inst Own | 93.00% |
Insider Trans | -4.24% | Inst Trans | -3.56% |
Short Float | 1.94% | Earnings | May 06/a |
Analyst Recom | 2.00 | Target Price | 21.17 |
Avg Volume | 1.38M | 52W Range | 12.11 - 19.43 |
|
|
|
Mueller Water Products, Inc. engages in the manufacture and sale of products used in the transmission, distribution, and measurement of water. It operates through the Water Flow Solutions and Water Management Solutions segments. The Water Flow Solutions segment includes iron gate valves, specialty valves, and service brass products. The Water Management Solutions segment focuses on fire hydrants, repair and installation, natural gas, metering, leak detection, pressure control, and software products. The company was founded in 1857 and is headquartered in Atlanta, GA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Takeuchi Kenji | SVP Water Management Solutions | May 16 '24 | Sale | 19.09 | 6,658 | 127,069 | 28,334 | May 16 06:27 PM | Healy Brian C. | Director | May 15 '24 | Buy | 19.18 | 2,650 | 50,818 | 2,650 | May 16 06:28 PM | Takeuchi Kenji | SVP Water Management Solutions | May 09 '24 | Option Exercise | 12.36 | 51,708 | 639,337 | 86,700 | May 10 06:12 PM | Takeuchi Kenji | SVP Water Management Solutions | May 09 '24 | Sale | 18.88 | 51,708 | 976,444 | 34,992 | May 10 06:12 PM | Van Arsdell Stephen C | Director | Mar 01 '24 | Buy | 15.42 | 10,000 | 154,200 | 80,603 | Mar 04 05:35 PM |
|
|
|
|
Market Cap | 130.38M | EPS (ttm) | -0.05 |
P/E | - | EPS this Y | 110.81% |
Forward P/E | 7.76 | EPS next Y | 312.50% |
PEG | - | EPS past 5Y | - |
P/S | 0.12 | EPS next 5Y | - |
P/B | 1.53 | EPS Q/Q | 58.56% |
Dividend | - | Sales Q/Q | -7.25% |
Insider Own | 93.22% | Inst Own | 0.22% |
Insider Trans | 0.05% | Inst Trans | 0.62% |
Short Float | 0.69% | Earnings | May 09/a |
Analyst Recom | 1.00 | Target Price | 5.12 |
Avg Volume | 20.18K | 52W Range | 0.65 - 4.10 |
|
|
|
Alliance Entertainment Holding Corp. engages in the distribution of music, movies, and consumer electronics. It distributes its physical media, entertainment products, hardware, and accessories through an established multi-channel strategy. The company was founded in 1990 and is headquartered in Plantation, FL. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Wielenga Terilea J | Director | May 15 '24 | Buy | 2.55 | 5,000 | 12,750 | 13,000 | May 16 06:11 PM | Donaldson Walter Tommy III | Director | May 14 '24 | Buy | 2.54 | 15,000 | 38,100 | 40,000 | May 16 06:09 PM | Wielenga Terilea J | Director | May 14 '24 | Buy | 2.55 | 3,000 | 7,650 | 8,000 | May 16 06:11 PM | Ogilvie Bruce A Jr | Director | Mar 01 '24 | Buy | 1.69 | 100 | 169 | 15,279,575 | Apr 25 04:01 PM | Ogilvie Bruce A Jr | Director | Feb 27 '24 | Buy | 1.65 | 200 | 330 | 15,279,475 | Apr 25 04:01 PM |
|
|
|
|
Market Cap | 52.49M | EPS (ttm) | -2.02 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | 0.28 | EPS next 5Y | - |
P/B | 1.06 | EPS Q/Q | -199.11% |
Dividend | 5.14% | Sales Q/Q | 0.86% |
Insider Own | 50.45% | Inst Own | 16.92% |
Insider Trans | 1.10% | Inst Trans | 6.84% |
Short Float | 0.91% | Earnings | May 14/b |
Analyst Recom | - | Target Price | - |
Avg Volume | 2.79K | 52W Range | 10.27 - 18.75 |
|
|
|
Ark Restaurants Corp. engages in the operation of restaurants and bars, fast food concepts, and catering operations. It operates in New York City, Florida, Washington, D.C, Las Vegas, NV, and the gulf coast of Alabama. The company was founded on January 4, 1983 and is headquartered in New York, NY. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
SATTERFIELD THOMAS A JR | 10% Owner | May 15 '24 | Buy | 15.30 | 3,322 | 50,827 | 55,922 | May 16 06:00 PM | SATTERFIELD THOMAS A JR | 10% Owner | May 15 '24 | Buy | 15.00 | 1,549 | 23,235 | 150,000 | May 16 06:00 PM | SATTERFIELD THOMAS A JR | 10% Owner | May 14 '24 | Buy | 14.43 | 8,844 | 127,643 | 190,000 | May 16 06:00 PM | SATTERFIELD THOMAS A JR | 10% Owner | May 14 '24 | Buy | 13.99 | 6,100 | 85,316 | 52,600 | May 16 06:00 PM |
|
|
|